(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OVODERM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OVODERM

ST13

US500000079270074

Class

1, 5

Filing

79270074

Registration

6055752

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

01/16/2026

Trademark type

Combined

Nice classes

1, 5

Filing date

08/13/2019

Registration date

05/19/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/19/2020

Last transaction

01/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

E-31132 VILLATUERTA, ES

Examiner

MARTIN,CHRISTINE C

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "OVODERM" with "OVO" appearing in white on a yellow oval next to "DERM" appearing in the color black.

Holders and representatives

Holders

EGGNOVO, S. L.

Representatives

Francis J. Duffin Wiggin and Dana LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Egg-based biological preparations for making cosmetic productsperfumery productspharmaceutical productsveterinary productsdietetic products for medicinal use and food for humans or animals

Class 5

Pharmaceutical and veterinary preparationspharmaceutical preparations for the prevention of osteoporosispharmaceutical preparations for the relief of painpharmaceutical preparations for the treatment of bone fracturespharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuriespharmaceutical preparations for the treatment of inflammatory muscle diseases and disordersveterinary pharmaceutical preparations for the treatment of arthritismuscle soreness and sprains; sanitary preparations for medical purposesegg sanitizing preparations; dietetic food and substances adapted for medical and veterinary usenutritional supplement meal and dietary fibre to aid digestion; baby food; dietary supplements for humans and animalsdietary supplements for general health and well-beingprotein supplements for animalsdietary supplements for well-being of muscles and joints; all the aforesaid preparations and supplements being derived from egg

Publications

History of USPTO decisions and trademark events.

28 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/15/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/19/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/25/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/11/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/21/2020

FIMP

FINAL DISPOSITION PROCESSED

09/21/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/19/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

05/19/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2020

PUBO

PUBLISHED FOR OPPOSITION

03/03/2020

GPNX

NOTIFICATION PROCESSED BY IB

02/28/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/12/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/12/2020

ALIE

ASSIGNED TO LIE

01/27/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/24/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/23/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/23/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/23/2020

RFNT

REFUSAL PROCESSED BY IB

12/28/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/10/2019

RFRR

REFUSAL PROCESSED BY MPU

12/10/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/15/2019

CNRT

NON-FINAL ACTION WRITTEN

11/14/2019

DOCK

ASSIGNED TO EXAMINER

11/12/2019

MAFR

APPLICATION FILING RECEIPT MAILED

10/29/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/24/2019

Continuous trademark protection

Get notified about every new filing that threatens OVODERM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.